News

Each Rare Cancer Accounts for less than 40,000 new cases each year.

Targeting Prevention to Reduce the High Human Toll of Rare Cancers

POSTED: October 1, 2024
SOURCE: Cancer Prevention Science Blog

At the Rare Cancers Prevention and Interception workshop this year, cancer researchers from across the United States, Canada, and the United Kingdom and from across disciplines sought to address many of the issues that can…
An illustration displaying signal amplification.
Engineering Synthetic Biomarkers for Early Detection of Cancers
Tumor cells release telltale molecules into blood, urine, and other bodily fluids. But it can be difficult to detect tumor-derived DNA, RNA, and proteins in the earliest stages of disease, when cancers can be easier to treat… Learn more
POSTED: 2/9/2022
SOURCE: Cancer Prevention Science Blog
AUTHOR: Jack J. Lee, Ph.D.
Illustration showing progression from normal liver to nonalcoholic steatohepatitis.
Study Identifies Potential Drug Target to Prevent Some Liver Cancers
While new cases of most cancer types have dropped over the past decade, cases of the most common type of liver cancer, hepatocellular carcinoma (HCC), are on the rise. Until recently, the main cause of HCC was hepatitis C… Learn more
POSTED: 2/4/2022
SOURCE: NCI Cancer Currents Blog
Partial screen grab of the ULACNet Zoom meeting showing a grid 9 participants.
ULACNet Update - January 2022
This issue recognizes January as Cervical Cancer Awareness Month by presenting four articles entitled, "ULACNet Annual Meeting: A Global Network Together in One (Zoom) Room", "Perseverance Through the COVID… Learn more
POSTED: 1/28/2022
SOURCE: DCP News
Photo of a health insurance statement.
Even If Insured, People with Advanced Cancer Often Face Financial Problems
Many people being treated for advanced cancer experience serious financial problems related to the cost of their care, even if they have health insurance, according to a new study.
POSTED: 1/26/2022
SOURCE: NCI Cancer Currents Blog
Executive Summary of the October 26-27, 2021 Cancer Screening Trial Network Workshop
The Division of Cancer Prevention (DCP) of the National Cancer Institute (NCI) hosted a virtual workshop to obtain information relevant to the potential creation of a new NCI-funded cancer screening clinical trials network… Learn more
POSTED: 1/25/2022
SOURCE: DCP News
Executive Summary of the NCORP Research Base Statistical Leads Meeting

A meeting of statistical leads from the seven NCI Community Oncology Research Program (NCORP) Research Bases with statisticians from the Division of Cancer Prevention (DCP) Biometry Research Group took place on July… Learn more
POSTED: 1/20/2022
SOURCE: DCP News
An illustration of a displaying a bronchoscopy, entering via nasal swabs to detect a suspicious nodule.
Identifying New Biomarkers to Detect Lung Cancer Earlier
Lung cancer, the leading cause of cancer deaths worldwide killing 1.8 million people each year, is often diagnosed at an advanced stage when the chances for a cure are limited.

In the United States, almost 60… Learn more
POSTED: 1/14/2022
SOURCE: Cancer Prevention Science Blog
AUTHOR: Jack J. Lee, Ph.D.